NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2026
Voltar para busca
Dado oficial do USPTO
BIOSSAYS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42
Data de depósito
23/02/2017
Data de registro
03/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/03/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Shenzhen, Guangdong, CN
Examinador
LEE, DOUGLAS
Unidade examinadora
M20
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of the word "BIOSSAYS".
Titulares e representantes
Titulares
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Representantes
Victoria Friedman Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drugs for medical purposes, namely, drugs for the treatment of tumor; Cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes, namely, biological preparations for the treatment of tumor; enzymes for medical purposes; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for the treatment of tumor; chemical preparations for medical purpose, namely, for the diagnosis of pregnancy; Medicated serums for the treatment of tumor; serotherapeutic medicines for the treatment of tumor
Classe 9
Calculating machines; data processing apparatus; Computer programs for use in medical instruments control and database management; computer peripheral devices; Computer software for use in medical instruments control and database management; computer monitors; Downloadable electronic publications, namely, books, hand-outs, workbooks in the fields of business; Downloadable computer programs for use in instruments control and database management; surveying apparatus and instruments
Classe 10
Corsets for medical purposes; Medical testing apparatus for in vitro diagnosis (IVD); Medical diagnostic apparatus for in vitro diagnosis (IVD); radiological apparatus for medical purposes; Medical analytical apparatus for in vitro diagnosis (IVD); suture materials; artificial limbs; massage apparatus; blood testing apparatus
Classe 42
Computer software design; computer programming; updating of computer software; computer system design; computer software consultancy; providing information on computer technology and programming via a web site; chemical research; Technical research in the field of medical devices; biological research; Conducting clinical trials for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/03/2024
71AG
REGISTERED-SEC.71 ACCEPTED
05/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/02/2024
ES71
TEAS SECTION 71 RECEIVED
20/06/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/04/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
20/02/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/09/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
13/07/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
13/07/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/07/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2018
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/02/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/02/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
26/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/01/2018
PUBO
PUBLISHED FOR OPPOSITION
16/01/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/12/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/11/2017
ALIE
ASSIGNED TO LIE
29/11/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/11/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/11/2017
CNFR
FINAL REFUSAL MAILED
18/08/2017
CNFR
FINAL REFUSAL WRITTEN
17/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/08/2017
RFNT
REFUSAL PROCESSED BY IB
24/06/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/06/2017
RFRR
REFUSAL PROCESSED BY MPU
05/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/05/2017
CNRT
NON-FINAL ACTION WRITTEN
22/05/2017
MAFR
APPLICATION FILING RECEIPT MAILED
19/05/2017
DOCK
ASSIGNED TO EXAMINER
18/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/05/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOSSAYS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.